Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies
Darren D O’Rielly, Proton RahmanFaculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland, CanadaAbstract: Rheumatoid arthritis (RA) is a chronic heterogeneous autoimmune disorder of unknown etiology resulting in inflammation in the synovium, cartilage, a...
Saved in:
Main Authors: | Darren D O’Rielly (Author), Proton Rahman (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
by: Francisco C. Ceballos, et al.
Published: (2023) -
Targeted therapy of rheumatoid arthritis via macrophage repolarization
by: Xu Zhou, et al.
Published: (2021) -
Implications of Peptidyl Arginine Deiminase 4 gene transcription and polymorphisms in susceptibility to rheumatoid arthritis in an Iranian population
by: Zahra Bagheri-Hosseinabadi, et al.
Published: (2023) -
Quercetin is a Potential Therapy for Rheumatoid Arthritis via Targeting Caspase-8 Through Ferroptosis and Pyroptosis
by: Zheng Q, et al.
Published: (2023) -
Ficolin-1 and ficolin-3 polymorphisms and susceptibility to rheumatoid arthritis
by: Cristhine Pieczarka, et al.
Published: (2020)